Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...
Eli Lilly inked two collaborations on Monday, one focused on cardiometabolic diseases with South Korea’s OliX Pharmaceuticals ...
Awareness of alcohol’s risk is low, especially among those recently diagnosed with cancer.
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
I saw this as something that I thought would change me,” said Clark Gamblin, a cancer surgeon in Milwaukee. “And change me ...
The report says drinking too much leads to around 100,000 cancer cases each year and 20,000 deaths. Alcohol is the third-leading preventable cause of cancer in the U.S., behind tobacco use and obesity ...
"They can drag it out till I'm not here anymore," Kirkland told KETV before he heard the news of the claim's reversal. "And then they win because ... they don't have to pay for it." ...
Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
Chloe Wakelin says her cancer symptoms were initially dismissed as a stomach bug that she picked up at her job as a daycare ...
The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...
Ten-year-old Pascual Cisneros is in remission from liver cancer and his dream of a cowboy shopping spree was granted Saturday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results